A randomized controlled trial examining the efficacy of motivational counseling with observed therapy for antiretroviral therapy adherence

AIDS and Behavior

Volumn 17, Issue 6, 2013, Pages 1992-2001

  Goggin, Kathy ^a   Gerkovich, Mary M ^b   Williams, Karen B ^b   Banderas, Julie W ^b   Catley, Delwyn ^a   Berkley Patton, Jannette ^a   Wagner, Glenn J ^c   Stanford, James ^b   Neville, Sally ^d   Kumar, Vinutha K ^e   Bamberger, David M ^b   Clough, Lisa A ^f  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c RAND CORPORATION   (United States)

^d Kansas City Urology Care   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Adherence; ART; Directly Observed Therapy; HIV AIDS; Motivational Interviewing

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICATION COMPLIANCE; METHODOLOGY; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; COGNITIVE THERAPY; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATIONAL INTERVIEWING; YOUNG ADULT;

EID: 84879055123     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0467-3     Document Type: Article

References (43)

1. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
2. Jones J, Taylor B, Wilkin TJ, et al. Advances in antiretroviral therapy. Top HIV Med. 2007;15:48-83.
3. Palella FJ, Chmiel JS, Moorman AC, et al. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS. 2002;16:1617-26.
4. Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15:1381-96.
5. Sethi AK. Adherence and HIV drug resistance. HIV Clin Trials. 2004;5:112-5.
6. Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285-97.
7. Hill S, Kavookjian J. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature. AIDS Care. 2012;24:583-92.
8. Simoni JM, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43:S23-35.
9. DiIorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14:52.
10. Golin C, Earp J, Tien HC, et al. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42-51.
11. Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4:121-31.
12. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-Steps and medication monitoring. Behav Res Ther. 2001;39:1151-62.
13. Altice FL, Maru DS, Bruce RD, et al. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45:770-8.
14. Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46:238-44.
15. Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community based directly observed therapy as an adherence intervention for HAART among substance abusers. AIDS. 2007;21:1473-7.
16. Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, Drobac PC, Shin SS. Effect of directly observed therapy for highly active antiretroviral therapy on virologic immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54-2:167-79.
17. Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet. 2009;374-9707:2064-71.
18. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11-9.
19. Beck JS. Cognitive therapy: basics and beyond. New York: The Guilford Press; 1995.
20. Goggin K, Liston R, Mitty JA. Modified directly observed therapy for ART: a primer from the field. Public Health Rep. 2007;122:472-81.
21. Grant KA, Tonigan JS, Miller WR. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 1995;56(2):168-72.
22. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
23. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609-29.
24. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2003) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL11102003004.pdf. Accessed 1 April 2013.
25. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2008) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL000988.pdf. Accessed 1 April 2013.
26. Banderas J, Thomson D, Gerkovich M, et al. Value of multi-modal standard care assessment in ART adherence research. In: 5th NIMH/IAPAC International Conference on HIV Treatment Adherence, Miami, 2010.
27. Miller W, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.
28. Finocchario-Kessler S, Catley D, Thomson N, et al. Patient communication tools to enhance ART adherence counseling in low and high resource settings. Patient Educ Couns. 2012;89(1):163-70. doi: 10.1016/j.pec.2012.03.
29. Harris KJ, Catley D, Good GE, et al. Motivational Interviewing for smoking cessation in college students: a group randomized controlled trial. Prev Med. 2010;51:387-93.
30. Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392-404.
31. Simoni JM, Amico KR, Smith L, et al. Antiretroviral adherence interventions: translating research findings to the real world clinic. Current HIV/AIDS Rep. 2010;7:44-51.
32. Sarna A, Luchters S, Geibel S, et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. J Acquir Immune Defic Syndr. 2008;48-5:611-9.
33. Chung MH, Richardson BA, Tapia K, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011;8(3):e1000422.
34. Parsons JT, Golub SA, Rosof E, et al. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443-50.
35. Safren SA, O'Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1-10.
36. Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83-93.
37. Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20:1295-302.
38. Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:1138-9.
39. Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340-6.
40. Gustafson DH, Shaw BR, Isham A, Baker T, Boyle MG, Levy M. Explicating an evidence-based, theoretically informed, mobile technology-based system to improve outcomes for people in recovery for alcohol dependence. Subst Use Misuse. 2011;46(1):96-111.
41. Rasu R, Malewski D, Thomson N, et al. Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2013;63:e1-e8.
42. Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460-5.
43. Bangsberg DR. Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. Curr HIV/AIDS Rep. 2009;6(4):173-4.